Dr. Nicolaides is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 E 32nd St
Fl 3
New York, NY 10016Phone+1 212-263-9959
Education & Training
- University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2004 - 2007
- NYU Grossman School of MedicineResidency, Pediatrics, 2001 - 2004
- New York University School of MedicineClass of 2001
Certifications & Licensure
- NY State Medical License 2003 - 2025
- CA State Medical License 2004 - 2019
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas Start of enrollment: 2014 Apr 29
Publications & Presentations
PubMed
- 171 citationsIntegrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsJonathon Torchia, Brian Golbourn, Shengrui Feng, King Ching Ho, Patrick Sin-Chan
Cancer Cell. 2016-12-12 - 54 citationsBromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System Tumors.Elizabeth Wadhwa, Theodore Nicolaides
Cureus. 2016-05-21 - 129 citationsA Kinase Inhibitor Targeted to mTORC1 Drives Regression in GlioblastomaQi-Wen Fan, Ozlem Aksoy, Robyn A. Wong, Shirin Ilkhanizadeh, Chris J. Novotny
Cancer Cell. 2017-03-13
Press Mentions
- New Mutations Enable Gliomas to Resist Proven Treatment, Study ShowsSeptember 24th, 2021
- For Children with Brain Tumors, Next-Generation Sequencing May Lead to Different Diagnoses, Less Toxic Targeted TreatmentsNovember 16th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: